These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review. Bellantuono C, Vargas M, Mandarelli G, Nardi B, Martini MG. Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291 [Abstract] [Full Text] [Related]
5. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine. Cutler N. Prim Care Companion CNS Disord; 2017 Feb 09; 19(1):. PubMed ID: 28196312 [No Abstract] [Full Text] [Related]
11. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database. Lin ND, Norman H, Regev A, Perahia DG, Li H, Chang CL, Dore DD. BMC Gastroenterol; 2015 Oct 14; 15():134. PubMed ID: 26467777 [Abstract] [Full Text] [Related]
12. Differences in the antinociceptive effects of serotonin-noradrenaline reuptake inhibitors via sodium channel blockade using the veratrine test in mice. Yoshizawa K, Suzuki Y, Nakamura T, Takahashi Y, Makino K, Takahashi H. Neuroreport; 2021 Jun 09; 32(9):797-802. PubMed ID: 33994525 [Abstract] [Full Text] [Related]
13. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature. Gicquel C, Moulis F, Chenaf C, Gouraud A, Drici M, Bondon-Guitton E, Montastruc F, Montastruc JL. Eur J Clin Pharmacol; 2017 Sep 09; 73(9):1197-1198. PubMed ID: 28639120 [No Abstract] [Full Text] [Related]
14. Differences in the placebo response in duloxetine and venlafaxine trials. Breilmann J, Furukawa TA, Becker T, Koesters M. Acta Psychiatr Scand; 2018 Jun 09; 137(6):472-480. PubMed ID: 29603140 [Abstract] [Full Text] [Related]
15. An investigation of the endocrine disrupting potential of enniatin B using in vitro bioassays. Kalayou S, Ndossi D, Frizzell C, Groseth PK, Connolly L, Sørlie M, Verhaegen S, Ropstad E. Toxicol Lett; 2015 Mar 04; 233(2):84-94. PubMed ID: 25625232 [Abstract] [Full Text] [Related]
16. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis. Renoux C, Lix LM, Patenaude V, Bresee LC, Paterson JM, Lafrance JP, Tamim H, Mahmud SM, Alsabbagh MW, Hemmelgarn B, Dormuth CR, Ernst P, Canadian Network of Observational Drug Effect Studies (CNODES) Investigators. Clin J Am Soc Nephrol; 2015 Oct 07; 10(10):1716-22. PubMed ID: 26231193 [Abstract] [Full Text] [Related]
19. The influence of a single and chronic administration of venlafaxine on tramadol pharmacokinetics in a rabbit model. Szkutnik-Fiedler D, Grabowski T, Balcerkiewicz M, Michalak M, Pilipczuk I, Wyrowski Ł, Urjasz H, Grześkowiak E. Pharmacol Rep; 2017 Jun 07; 69(3):555-559. PubMed ID: 28364695 [Abstract] [Full Text] [Related]
20. Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. Hecker M, Newsted JL, Murphy MB, Higley EB, Jones PD, Wu R, Giesy JP. Toxicol Appl Pharmacol; 2006 Nov 15; 217(1):114-24. PubMed ID: 16962624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]